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A STUDY OF CARBOHYDRATE METABOLISM IN SCLERODERMA*
PRELIMINARY REPORT
RAUL FLEISCHMAJER, M.D.t AcID GEORGINA FALUDU
Scieroderma is a well recognized clinical
entity which has been known to the physician
for more than 200 years. This mcsenchymal dis-
order has been the subject of numerous clinical,
pathological and biochemical investigations, yet
its pathogenesis remain entirely unknown.
During the past 2 years we studied several
kidney biopsies from scicroderma patients by
means of light microscopy with the Periodic
acid-Schiff stain (PAS). None of these patients
had significant impairment of kidney function
except for a few who had a mild reduction in
the glomcrular filtration rate. The most striking
histological findings were a diffuse or focal in-
crease in the width of the basement membrane
of the glomeruli, mesangial thickening and
hyalinization of arterioles. Since the above
findings have been noted in prcdiabctcs and in
diabetes mellitus, (1—3) we were prompted to
perform glucose tolerance tests (OTT) and
plasma immunoreactive insulin (IRI) deter-
minations in patients affected with scleroderma.
MATERIAL AND METHODS
Fifteen cases with systemic and one with
localized scleroderma were studied. There were 14
females and 2 males; their ages ranged from 10
to 63 years old. All of the patients with systemic
scleroderma had the acroselerotic type, while the
single patient with localized scleroderma had
widespread morphea (Case 10). None of these
patients had clinical diabetes, except for symp-
toms of functional hypoglycemia in 3 cases.
The following controls were used: eleven nor-
mals, eleven patients with early latent diabetes
and 5 with latent (or chemical) diabetes. The
normals were individuals of normal weight, nega-
tive family history for diabetes and glucose
tolerance test with fasting levels below 106 mg%,
less than 160 mg% at 1 hour, less than 120 mg% at
2 hours and below 100 mg% at three hours. These
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criteria for a normal glucose tolerance test are a
slight modification of that proposed by Mosenthal
and Barry (4) who used an upper limit for the 1st
hour of 150 mg%. We define as early latent dia-
betics obese individuals with normal fasting glu-
cose levels, less than 160 mg% at the 1st hour, less
than 120 mg% at the 2nd hour but with functional
hypoglycemia, usually noted at the 4th hour of
the oral glucose tolerance test (5). We define as
latent or chemical diabetics, those patients with
the following glucose tolerance curve: normal
fasting levels with the 1 hour value exceeding
160 mg% and the 2 hour value above 120 mg%.
All scleroderma patients were ambulatory, and
their diets included adequate intake of carbohy-
drates. There were no symptoms of intestinal
malabsorption in this series. None of the patients
were on systemic corticosteroids for at least 1
year prior to the time of this investigation. More-
over, none of them were on treatment with drugs
known to affect insulin release or glucose metabo-
lism. Following an overnight fast, the first blood
sample was drawn by venepuncture. After the
ingestion of 100 grams of glucose (50 grams for
Case #13 who was 10 years old) blood samples
were drawn at half, 1, 2, 3, 4, and 5 hours. Blood
sugar was determined with an Auto-analyzer uti-
lizing a modification of Hoffman's method (6).
Radio-immuno assay of plasma insulin was done
by a modification of the method described by
Hales and Handle (7). (Data sheet #5581 of the
Radiochemical Center, Amersham, Buckingham-
shire, England.)
RESULTS
On the basis of the OTT, the patients were
divided into two groups. In Group I the 1st
hour reading was above 160 mg% and the 2nd
hour above 120 mg%. Ten patients showed this
pattern, which is similar to that seen in latent
or chemical diabetes. Group II had a 1st hour
reading below 160 mg% while the 2nd hour
was either above or below 120 mg%. There
were six patients in this group of which 2
showed 2nd and 3rd hour levels above 120 mg%
while the other 4 had normal or flat curves
(see Table 1). In the two groups a tendency
for hypoglycemia was noted in S patients.
The levels and curve distribution of im-
munoreactive insulin were not uniform but
were abnormal in all of the acleroderma pa-
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TABLE I
Blood glucose and plasma insulin concentrations in scleroderma
Case No.
Blood glucose(mg/100 ml) Plasma insulin (pU/mI)
Fasting ½ 1 2 3 4 5 Fasting 3.9 1 2 3 4 5
hours hours
Group I
1
2
3
4
5
6
7
8
9
10
96
98
98
86
84
85
105
91
100
75
153
169
180
154
164
150
197
131
175
111
196
162
211
222
202
166
199
163
231
165
201
150
153
189
242
199
186
131
170
153
152
140
154
155
69
100
129
123
56
107
62
86
96
69
59
97
76
109
69
93
54
76
61
67
84
58
66
67
84
51
31
25
10
105
12
25
37
21
16
16
237
62
74
275
202
64
71
66
17
44
410
68
100
650
87
240
69
65
210
100
790
52
185
540
560
130
147
117
300
110
700
44
235
370
92
115
115
125
35
75
175
28
110
155
25
54
22
54
23
59
80*
42
72
112
14
26
32
10
14
18
Group II
11
12
13
14
15
16
94
75
114
101
91
86
149
152
138
111
138
130
147
126
112
102
141
131
131
161
91
79
106
100
125
124
101
102
100
120
92
96
94
68
81
113
84
52
100
95
84
118
13
10
23
27
29
53
96
185
130
69
57
52
110
360
295
115
135
67
99
347
145
99
—
49
39
212
190
86
109
63
76
82
120
27
28
56
10
61
122
10
28
86
* This determinationwas performed at 4:05 hours because of hypoglycemic shock.
TABLE II
Blood glucose and plasma insulin concentrations during oral glucose tolerance test
Blood glucose (mg 100 ml) Plasma insulin (joU ml)
Fast ½ 1 2 3 4 Fast ½ 1 2 3 4 5
Scieroderma
Group I (10)
Group II (C)
Normal (11)
Early latent di-
abetes(11)
Latent diabetes
(5)
92
3
94±
S
86±
1
88
1
89±
2
158
7
136
6
124
3
119
2
147
3
192
8
127
6
138
1
143
2
168
2
hours
177
10
111
11
98
1
95
2
135
3
119
11
112
5
87
0.6
89
1
124
2
82±
5
91±
6
88±
1
41
2
87±
4
67
4
89
8
86
0.4
76
1
94
6
30±
8
26±
6
19±
1
33
2
38±
8
111 200
27 58
98 180
19 44
97 90
3 4
69 127
2 5
44 112
10 16
hours
293
75
148
47
54
2
143
6
134
25
191
62
117
26
42
2
152
5
148
23
71
17
65
13
20
1
172
12
130
27
42
10
53
17
16
1
128
7
72
20
* Mean and SEM.
Figure in parentheses indicates the number of patients.
tients included in this series. In Group I six lower concentration of insulin, although the
patients showed hyperinsulinism with the peak curve was of a delayed type. Only Case 2
usually taking place during the 1st or 2nd hour showed a low and flat curve although, at the
following the oral glucose load (Cases 1, 3, 4, 5 5th hour the insulin levels were still above those
6, 9). Three patients (Cases 7, 8, 10) showed a of the fasting sample. In Group II, two cases
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showed hyperinsulinism (Cases 12, 13) while
the others revealed a delayed curve.
Normals showed the peak of insulin activity
at half an hour, followed by about a 50% re-
duction by the 2nd and 3rd hour, and returning
to about fasting levels by the 4th to 5th hour.
The early latent and latent diabetics showed a
delayed insulin response, with the peak of ac-
tivity at the 3rd-4th hour and remaining
above fasting levels at the 5th hour (see Table
II).
COMMENTS
This study revealed a high incidence of ab-
normal OTT in seleroderma. The IRI showed
hyperinsulinism and or a delayed type of curve
pattern.
There was no correlation between the insulin
curves and the presence of obesity. In this
series only 2 patients could be classified as
obese (Cases 1, 15), two were underweight(Cases 5 and 13) while the other 12 had
weights within normal limits. This is particu-
larly noteworthy in view of recent reports
suggesting that obesity and not diabetes mel-
litus itself is responsible for insulin hyper-
secretory responsiveness (8, 9).
Since the basic defect in diabetes mellitus is
not known, it is , at present, impossible to as-
certain whether the carbohydrate abnormality
in scleroderma represents genetically deter-
mined diabetes or whether it belongs to the
group of secondary hyperglycemias such is
seen in acromegaly, liver cirrhosis, pancreatitis,
etc. In this regard there were six patients with
a positive family history of diabetes in Group
I and two in Group II. Further one may raise
the question as to whether kidney involvement
in scleroderma may be related to the presence
of latent diabetes.
The possible relationship between a carbo-
hydrate abnormality and the connective tissue
alterations observed in scleroderma is open for
speculation. In this regard, une of us (RF) re-
cently reported an increase in collagen bound
hexosamines in the dermis from sclerodcrma
patients (10). The hypothesis that collagen
may chemically interact with some carbohy-
drates was demonstrated in a recent study in
which chemical analysis of a purified hyaline
revealed it to consist of collagen with a sig-
nificant increase in bound hexoses and hexos-
amines (11).
We believe that the possible relationship be-
tween abnormalities in carbohydrate metabo-
lism and connective tissue pathology should be
investigated in sclcroderma as well as in dia-
betes mellitus.
SUMMARY
Blood glucose and plasma immunoreactive
insulin levels were measured during a 5 hour
oral glucose tolerance test in a series of sixteen
patients with scleroderma. Normals, early la-
tent and latent or chemical diabetics were used
as controls. There was a high incidence of ab-
normal glucose tolerance tests in scleroderma
patients with a pattern similar to that seen
in latent or chemical diabetes mellitus. Tm-
munoreactive insulin levels revealed an in-
creased output and or a delayed type of re-
sponse. The possible implications between
carbohydrate metabolic derangements and con-
nective tissue pathology are discussed.
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